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Background: Plasma angiopoietin (Ang)-2 is associated with disease severity and mortality in adults and children
with falciparum malaria. However the mechanism of action of the angiopoietins in fatal malaria is unclear. This
study aimed to determine whether the expression of Ang-1 and Ang-2 and their receptor Tie-2 in cerebral
endothelial or parenchymal cells was specific to cerebral malaria (CM), correlated with coma or other severe clinical
features, and whether plasma and CSF levels of these markers correlated with the clinical and neuropathological
features of severe and fatal malaria in Vietnamese adults.
Methods: Immunohistochemistry was performed for Ang-1, Ang-2 and Tie-2 on post-mortem brain tissue from
fatal malaria cases and controls. Quantitative ELISA for plasma and cerebrospinal fluid levels of Ang-1, Ang-2 and
Tie-2 was done to compare fatal cases with surviving patients from the same study.
Results: Immunohistochemistry revealed significant differences in expression in endothelial and parenchymal cells
compared to controls. However there was no significant difference in expression of these markers on endothelial
cells, astroglial cells or neurons between CM and non-cerebral malaria cases. Immunostaining of Ang-1, Ang-2 and
Tie-2 was also not associated with Plasmodium falciparum-infected erythrocyte sequestration in the brain. However
Ang-1 and Ang-2 expression in neurons was significantly correlated with the incidence of microscopic
haemorrhages. Plasma levels of Ang-2 and Ang-2/Ang-1 ratio were associated with the number of severe malaria
complications and were significant and independent predictors of metabolic acidosis and fatal outcome.
Conclusions: The independent prognostic significance of Ang-2 and the Ang-2/Ang-1 ratio in severe malaria was
confirmed, although immunohistochemistry in fatal cases did not reveal increased expression on brain endothelium
in cerebral versus non-cerebral cases. Activation of the Ang-Tie-2 pathway in severe malaria is therefore related to
acidosis, number of severity criteria and outcome, but is not a specific event in the brain during cerebral malaria.
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Malaria continues to be a major cause of mortality and
morbidity in tropical countries [1]. Severe Plasmodium fal-
ciparum malaria, is characterized clinically using a series of
criteria (WHO, 2000) [2], including complications such as
hyperparasitaemia, metabolic acidosis, acute renal failure,
severe anaemia and coma, presenting as cerebral malaria
(CM). CM is a neurological syndrome comprising a poten-
tially reversible diffuse encephalopathy, associated with
retinopathy and variably with convulsions and localizing
neurological signs, which are poor prognostic features [3].
The pathogenesis of CM is complex and multifactorial.
A fundamental pathophysiological question in the genesis
of coma in CM is how parasitized red blood cells (PRBC),
remaining within the vascular space, influence parenchy-
mal function to induce coma and death. Neurological dys-
function in severe malaria is significantly related to the
sequestration of PRBC in the cerebral microvasculature,
and resultant microvascular obstruction [4-7]. Both local
and systemic factors may contribute to endothelial activa-
tion and blood brain barrier (BBB) dysfunction, causing
secondary neuropathological processes such as neuronal
and astroglial dysfunction or axonal injury [8].
The endothelium, which is the critical interface between
PRBC and the brain parenchyma, is considered to be cen-
tral to the pathogenesis of CM. During severe malaria
infection, there is systemic activation of EC including the
cerebral EC of the BBB [9,10]. Activated endothelium has
increased permeability through the disruption of endothe-
lial transmembrane proteins, and shows upregulation of a
variety of surface adhesion molecules including intercellu-
lar cell adhesion molecule-1 (ICAM-1), vascular cell adhe-
sion molecule-1 (VCAM-1), P- and E-selectin [9,11-14].
Moreover, activated ECs rapidly exocytose pre-synthesized
and stored molecules from Weibel-Palade bodies (WPB)
in response to changes in the vascular micro-environment.
Although the main constituent of WPB is von-Willebrand
factor (vWF) and its propeptide, other molecules includ-
ing P-selectin, CD63, interleukin-8, endothelin-1, tissue
plasminogen activator and angiopoietin (Ang)-2 are also
released. The release of WPB is the initial step in the tran-
sition from a resting endothelial phenotype to activated re-
sponsive endothelium [15-18].
The Ang-Tie-2 ligand-receptor system is a key regulator
of the maintenance of functional integrity in both quies-
cent and activated endothelium [19]. In most contexts,
Ang-1-mediated Tie-2 signalling maintains endothelium
in a steady state but Ang-2, which functions as an antag-
onist ligand of Tie-2, can destabilize this and sensitize
endothelial response to inflammatory and angiogenic cyto-
kines such as tumour necrosis factor (TNF), interleukin-1
and vascular endothelial growth factor (VEGF) [13]. In
order to maintain the quiescent phenotype of endothe-
lium, ECs need constitutive Tie-2 signalling mediated byAng-1 binding, which is mainly released from pericytes,
fibroblast and smooth muscle cells and incorporated into
extracellular matrix after secretion [20]. Tie-2 phosphoryl-
ation involves several downstream signalling pathways
including activating phosphatidylinositol 3-kinase and
protein kinase B pathways, and inhibiting nuclear factor
(NF)-κB [21]. These pathways protect cells from apoptosis
and loss of intercellular junctional complexes and inhibit
inflammatory responses. Exogenous stimuli such as phys-
ical damage, hypoxia or impaired endothelial nitric oxide
production cause rapid exocytosis of stored Ang-2 in WPB
from the ECs and competitively bind to Tie-2 receptor,
which negatively interferes with constitutive Ang-1-
mediated Tie-2 signalling [18,22,23]. Consequently, Ang-
2-Tie-2 binding results in destabilization of endothelium
and enhances EC responsiveness to other cytokines. Ang-2
can, therefore, act as an autocrine dynamic regulator of
the rapid adaptive response of endothelium [13].
Recent in vivo studies have implicated the dysregula-
tion of angiopoietins in the pathogenesis of severe and
fatal malaria. In adults with cerebral and non-cerebral
severe malaria, plasma Ang-2 has been associated with
reduced endothelial nitric oxide bioavailability and mor-
tality with Ang-2 a better predictor of death than venous
lactate [24]. In children, increased plasma Ang-2 and the
Ang-2/1 ratio, and reduced Ang-1 have been associated
with disease severity and risk of death in CM [25-29].
Nevertheless, the mechanisms by which Ang-Tie-2 path-
way contributes to CM and non-cerebral severe malaria
(NCM), and fatal outcome, remain unclear.
The therapeutic use of angiopoietins has been investi-
gated in experimental murine models of brain ischemia,
where Ang-1 inhibits BBB breakdown, stimulates the
recruitment of neuroblasts and promotes behavioural
recovery [30]. The Ang-Tie-2 signalling pathway could
potentially be a logical target for neuroprotective ad-
junctive therapy in CM. However their tissue specific
expression and specificity in a target organ such as the
brain has not been studied in human fatal malaria cases.
Therefore, in this study, the site and expression levels
of the proteins Ang −1 and −2 and their receptor Tie-2
were examined in brain tissue of patients who died from
malaria, to determine whether there were patterns of
expression specific to cerebral malaria. Levels of the cir-
culating forms of these proteins were examined in
plasma and CSF of a subset of these patients in order to
correlate circulating angiogenic protein levels and their
expression patterns in the brain with the clinical mani-
festations of severe malaria.
Methods
Ethical approvals
This retrospective case–control research study used
archival brain, plasma and CSF specimens of fatal and
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double-blinded trial of artemether versus quinine for the
treatment of severe malaria in Vietnam (AQ trial) [31].
Relatives gave written informed consent for entering the
study. The brain specimens of non-malaria cases (normal
controls) were from a collection of routine autopsy cases at
John Radcliffe Hospital, Oxford, UK, where specific written
consent for retention of brain tissue for research purposes
had been given. Protocols for tissue sampling, storage and
use for research were approved by the Ethical and Scientific
Committee of the Centre for Tropical Diseases in Ho Chi
Min City, Vietnam, OXTREC 029–02, COREC (C01.002)
and Human Tissue Authority license number 12217.Figure 1 Schematic diagram to summarise case and sample selection
material was available, and as far as possible matching CSF and plasma sam
study material to expand the numbers of fatal cases and survivors.Selection of cases
Malaria and non-malaria cases
A total of 81 adults were included in this clinicopathologi-
cal study (Figure 1). Of 81, 63 were severe malaria cases
selected from the AQ trial [31], admitted at the centre for
Tropical Diseases in Ho Chi Min City, Vietnam between
1991 and 1995. These were diagnosed with malaria using
serial blood films and subsequent blood PCR. All were
classified according to the WHO 1990 criteria for severe
falciparum malaria [32]. Eighteen of the 81 were normal
controls from routine autopsy at John Radcliffe Hospital
(Oxford, UK). These normal controls had clinically con-
firmed multi-organ dysfunction and a variety of different. Samples were chosen through utility – cases where FFPE histological
ples to these cases, plus randomly selected other cases from the AQ
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neuropathological examination as previously detailed [33].
Brain specimens
In total, 41 cases were used. Twenty-three fatal malaria
patients from the AQ study were examined, 13 of which
were defined on WHO criteria as dying with CM and 10
were non-cerebral malaria (NCM). Brain sections from
18 normal controls from the UK were also used. For the
malaria patients, brain specimens were collected at aut-
opsy within 24 hours (median 7 hours), fixed in 10% for-
malin, then embedded in paraffin and processed using
standard methods as previously described [34]. Clinical
details of fatal malaria and control cases are shown in
Additional files 1 and 2, respectively.
Plasma and CSF specimens
Plasma samples from 62 out of 63 severe malaria cases
were used for the quantitation of the angiogenic proteins
by ELISA. CSF samples were available from only 12 se-
vere malaria cases. Venous blood samples were taken
immediately after admission into EDTA anticoagulant.
Plasma samples were generated by centrifugation at
5,000 g for 3 min, then aliquoted and stored at −80°C
until use. CSF was taken when the procedure was clinic-
ally indicated, aliquoted neat without any additives, spun
and frozen at −80°C until use [35].
Clinical, biochemical and neuropathological data for
correlations
The cases used in this retrospective study had subsequent
extensive clinical, biochemical and neuropathological
investigations [31,33-38]. These existing data were corre-
lated with immunostaining scores and plasma levels of
Ang-1, Ang-2 and Tie-2 proteins generated from this
study. These included assessment of the number of criteria
of severe malarial disease, coma status, biochemical evi-
dence of other end organs disease such as creatinine level
for renal failure, liver function tests and lactate, peripheral
blood counts for anaemia, white cell count and platelet
levels, and neuropathological quantitation of sequestra-
tion, malarial haemorrhages and degree of oedema in indi-
vidual cases. Data on CSF levels of the neurotransmitters
quinolinic acid and kynurenine ratios [35] were also used.
Detection and quantification of Ang-1, -2 and Tie-2
proteins in the brain
Immunohistochemistry
Immunohistochemistry (IHC) was performed for three dif-
ferent markers of Ang-Tie-2 pathway including the Ang-1
protein, Ang-2 and Tie-2 receptor. Staining was performed
on 4 mm sections of formalin-fixed paraffin embedded
brain blocks cut onto coated immunoslides (SupaFrost),
from all malaria and control cases. The sections weredewaxed in xylene, rehydrated in graded alcohol series
and then underwent microwave antigen retrieval in Tris-
EDTA pH 8 for 10 min. The primary antibodies used
were: Ang-1 (mouse polyclonal, A0604, Sigma, UK, 1:20
dilution), Ang-2 (rabbit polyclonal, Ab65835-100, Abcam,
UK, 1:50 dilution) and Tie-2 (rabbit polyclonal, SC-9026,
Santa Cruz, USA, 1:100 dilution). Detection of bound anti-
body was visualized using the high-sensitivity Novolink™
Polymer detection system (Leica Biosystems, UK). Negative
controls comprised sections immunostained as above with
omission of the primary antibody.
Three areas of the brain from each case were examined
including cortex, diencephalon and brain stem, to deter-
mine any site specific variations in the patterns of immu-
noreactivity. With each brain area, the pattern and intensity
of staining were examined in three different cellular com-
ponents including vessels, neurons and astroglial cells.
Quantitation of vascular immunostaining
Vessels were considered positive for Ang-1, Ang-2 and
Tie-2 when any parts forming the vessel including ECs,
basement membrane, pericytes or smooth muscles were
stained. The number of positive vessels in 150–300 fields
in each slide at x200 magnification was used to calculate
the number of positive vessels per centimetre squared. The
continuous variable of number of positive vessels per cm2
was converted to a semiquantitative Vascular Expression
Score (VasExp) as follows: Ang-1; low = 0–20 vessels/cm2,
moderate = 20–40 vessels/cm2, high ≥40 vessels/cm2: Ang-
2; low = 0–200 vessels/cm2, moderate = 200–400 vessels/
cm2, high ≥400 vessels/cm2: Tie-2; low = 0–10 vessels/cm2,
moderate = 10–20 vessels/cm2, high ≥20 vessels/cm2. Both
scores were used in histopathological and clinicopathologi-
cal correlations where continuous or semiquantitative cat-
egorical measurements where most appropriate.
Semiquantitation of neuronal and astroglial
immunostaining
Ang-1 and Ang-2 expression on neurons and astroglial
cells was classified in a semi-quantitative scoring system
of both the number of cells and the intensity of expres-
sion. Cell numbers were classified according to a per-
centage score as follows: score 0 = percentage of stained
cells 1% or less, score 1 = 1-10%, score 2 = 10-50% score
3 ≥50%. The intensity score was defined as: score 0 = no
staining, score 1 = weak staining (+/−), score 2 = moderate
staining (+), score 3 = strong staining (++). The neuronal
expression (NeuExp) of Ang-1 and Ang-2 was represented
as the sum of the percentage score and intensity score
(NeuScore) and also divided into two groups of “low” (low
NeuExp, NeuScore ≤3) and “high” neuronal expression
(high NeuExp, NeuScore ≥4). Astroglial expression
(GliExp) of Ang-1 and Ang-2 was classified based on a
similar system combining the percentage score with the
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“high” astroglial expression (high GliExp, GliScore ≥4).
However, due to much lower expression of Tie-2 on neu-
rons and astroglia cells, it could not be quantitated using
the same scoring system as Ang-1 and Ang-2. Rather
than using both the number of cells and the intensity of
staining, the semi-quantitative scoring system for Tie-2
expression on neurons and astroglial cells was based on
the number of cells staining as follows: “low” neuronal or
astroglial expression (low NeuExp or GliExp) = percent-
age of stained cells 1% or less and “high” neuronal or
astroglial expression (high NeuExp or GliExp) = percent-
age of stained cells >1%.Quantification of Ang-1, -2 and Tie-2 proteins in the plasma
and CSF
Plasma and CSF concentrations of Ang-1, Ang-2 and Tie-2
were measured by quantitative ELISA (R&D Systems, UK),
according to the manufacturer’s instructions, each sample
tested in duplicate. Concentrations were interpolated from
5-parameter-logistic (5-PL) standard curve fitting, using
the manufacturer’s recombinant human Ang-1, Ang-2 and
Tie-2 proteins.
A total of 62 plasma samples and 12 CSF samples from
patients of severe malaria were examined, all in duplicate.
Twenty-two of the 62 plasma samples and 12 CSF samples
were from fatal malaria cases included in the immunohis-
tochemical analysis. The other 40 plasma samples were
from severe malaria patients in the same AQ trial, selected
randomly, including fatal cases (n = 10/40) and survivors
(n = 30/40).Statistical methods
Analyses were performed using Stata/SE 9.2 (StataCorp
LP, Texas, USA), with a P value less than 0.05 taken as
being statistically significant. Continuous variables were
tested for normal distribution with the Kolmogorov-
Smirnov test, (this showed that the distribution of all
continuous variables measured was not normal). Thus
data were summarized with median and interquartile
values, and non-parametric tests, including Kruskal-
Wallis, Mann–Whitney U test, and Wilcoxon matched-
paired signed-ranks test were used to compare groups
where appropriate. Correlations between continuous
variables were tested by Spearman’s rank correlation.
For IHC expression score data: due to the correlated
nature of data obtained from different areas of the brain
within the same patient (three areas of the brain from
one patient), intraclass correlation, which affected the
standard errors of the estimates, were taken into account
by using clustered robust standard errors (one patient as
one cluster) with univariate logistic or ordered logistic
regressions where appropriate.The prognostic value of plasma angiopoietins, Tie-2
and other biomarkers was assessed by calculating the
area under the receiver operating characteristic curve
(AUROC). The AUROCs were compared nonparametri-
cally by DeLong’s method.
Multivariate analyses were conducted by either linear
regression or logistic regression, depending on the na-
ture of the dependent variable. Stepwise techniques were
used manually in the light of clinical judgments where
appropriate.
Results
Patterns of Ang-1, Ang-2 and Tie-2 immunostaining in
the brain
Ang-1, Ang-2 and Tie-2 staining could be found in the
cytoplasm and/or nucleus of a range of cells, including
neurons, astroglial cells, ECs, pericytes, and perivascular
smooth muscle cells, in the brain sections of malaria and
non-malaria patients (Figure 2). There was considerable
heterogeneity in the expression of Ang-1, Ang-2 and Tie-2
between patients and different brain areas of each patient.
The expression of Ang-1 and Ang-2 was more commonly
seen on larger neurons or astroglial cells than smaller
neuron or astroglial cells. All three proteins could be seen
staining vascular components including ECs, pericytes
and perivascular smooth muscles, but Ang-1 expression
was almost never seen on ECs. All three angiogenic mar-
kers were also observed in axonal fibres, intravascular
serum and red blood cells either with or without parasites.
However, Tie-2 staining on astroglial cells was exclusively
found in malaria cases and not constitutive in controls.
Comparative quantitation of Ang-1, Ang-2 and Tie-2
expression between different areas of the brain
The expression of each marker was compared between
the three different brain areas and in different cellular
components. Detailed analysis of staining patterns of all
cases (pooled malaria cases and non-malaria controls)
and of malaria cases only is presented in Additional files
3 and 4, respectively.
Immunostaining of Ang-1, Ang-2 and Tie-2 differentiates
malaria cases from controls but not cerebral malaria from
non-cerebral malaria
Because the circulating levels of Ang-1, Ang-2 and Ang-2/
Ang-1 ratio have been reported to be clinically informative
biomarkers for CM, we examined the expression patterns
of proteins Ang-1, Ang-2 and their receptor Tie-2 in the
brain tissue of patients dying of CM and compared them
to NCM. No significant differences were found between
the immunostaining patterns of Ang-1, Ang-2 and Tie-2
on all three cellular components including neurons,
astroglial cells and vessels in CM cases compared to NCM
(Figure 3). However, there were significant differences in
Figure 2 The immunostaining of Ang-1, Ang-2 and Tie-2 in brain sections from fatal malaria cases (A, B, C, F) and fatal non-malaria
cases (D, E). There was heterogeneity in expression patterns of Ang-1, Ang-2 and Tie-2 between patients and within different brain regions in
each patient. (A, D) Ang-1 was more commonly seen on larger neurons or astroglial cells, perivascular smooth muscles and pericytes, but not
usually on endothelial cells (ECs). Strong staining was occasionally observed on neuropil and axonal bundles. (B, E) Strong Ang-2 labelling on
axonal bundles, large neurons, astroglial cells, perivascular smooth muscles, pericytes, ECs and some parasitized red blood cells. (C, F) Strong Tie-2
staining of large and small neurons, astroglial cells, perivascular smooth muscles, pericytes and ECs. (F) A larger vessel showing Tie-2 staining
whilst surrounding capillaries, showing significant parasitized erythrocyte sequestration, are completely negative. All sections were counterstained
with haematoxylin. Scale bars = 60 μm. Abbreviations: AX = axons, G = astroglial cells, N = neurons, P = parasitized red blood cells, V = vessels.
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2 in malaria cases compared to non-malaria cases, espe-
cially in neurons and astroglial cells. Summaries of the
staining patterns and odds ratios are shown in Figure 4.Ang-1
The incidence of high Ang-1 expression on neurons and
astroglial cells was greater in malaria cases (73.91%,
79.71%, respectively), compared to non-malaria cases
(35.19%, 24.07%, respectively) (P < 0.001). Ang-1 expres-
sion on vessels did not differ between malaria and non-
malaria cases.Ang-2
The incidence of high Ang-2 expression on neurons was
greater in brain sections of malaria cases (65.22%), com-
pared to non-malaria cases (33.33%) (P = 0.002). Ang-2
astroglial expression was lower in malaria compared tonon-malaria (P = 0.078); which became statistically sig-
nificant after adjusting for age and sex (P = 0.038).
Tie-2
Reduced expression of Tie-2 was observed in astroglial
cells of malaria cases, all slides of malaria cases (100%) did
not express Tie-2 on astroglial cells, compared to 77.78%
of non-malaria cases (P <0.001, Fisher’s exact). The vascu-
lar expression of Tie-2 was significantly higher in malaria
cases (high VasExp 40.58%), compared to non-malaria
cases (low VasExp 11.1%) (P = 0.049). There was a trend
of increased incidence of Tie-2 neuronal expression in
malaria compared to non-malaria (P = 0.059).
Increased expression of Ang-1 and Ang-2 in neurons is
associated with microscopic haemorrhages
Microscopic cerebral haemorrhages are a common but
non-specific neuropathological finding in CM [8]. Two
main types of haemorrhage are seen including simple
Figure 3 Immunostaining patterns for Ang-1, Ang-2 and Tie-2 differentiated control from malaria cases. Graphs show percentages of
cases positive according to marker, cell components and expression scores. The immunostaining patterns of Ang-1, Ang-2 and Tie-2 in malaria cases
were significantly different from those in non-malaria cases, especially the staining for neuronal and astroglial components. However, these proteins
were not differentially expressed in CM compared to NCM. (*Logistic Regression with clustered robust standard errors, **Fisher's Exact Test,
***Ordered Logistic Regression with clustered robust standard errors).
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(Figure 5). Both types of haemorrhage are not exclusively
specific to CM, but also present in NCM and other dis-
eases such as bacterial infections and thrombotic phenom-
ena such as bone marrow embolism or barotrauma. They
represent focal damage to the microvasculature and hence
the regulation of EC barrier function. Therefore, we exam-
ined the correlation between immunostaining patterns of
Ang-1, Ang-2 and Tie2 and microscopic haemorrhage in
the brain.
Within the brain sections of malaria cases in this study,
40.6% showed haemorrhages. Petechial haemorrhages(88.9%) were more common than ring haemorrhage
(11.1%). No significant difference in the incidence of hae-
morrhages was found between CM and NCM in this
series. There was no correlation between the vascular or
astroglial expression of Ang-1, Ang-2 or Tie-2 and the in-
cidence or number of haemorrhages per cm2. However,
high NeuExp of Ang-1 (OR = 7.11, 95%CI = 1.50-33.64)
was associated with the presence of microscopic haemor-
rhages (P = 0.013).
Taking all clinical groups (malaria and non-malaria) into
account, high NeuExp of Ang-1 (OR = 13.30, 95%CI =
3.27-54.09) and Ang-2 (OR = 5.5, 95%CI = 1.77-17.01)
Figure 4 Summary of the expression pattern of angiogenic
proteins in the brain of fatal malaria patients compared with
fatal non-malaria patients. Using immunohistochemistry, increased
expression of Ang-1 in neurons and astroglial cells, increased
expression of Ang-2 in neurons, and increased expression Tie-2 in
vessels were observed in the brain of fatal malaria patients
compared to fatal non-malaria patients. Decreased expression of Tie-2 in
astroglial cells was observed in fatal malaria cases. Values are odds ratios
(brackets = 95% confidence intervals) of higher expression scores
(NeuExp, GliExp or VasExp) in malaria compared to control patients.
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rhage (P = 0.003, P <0.001, respectively).Immunostaining of Ang-1, Ang-2 and Tie-2 is not
associated with parasite sequestration in the brain
No correlation was found between the degree of PRBC
sequestration in cerebral microvessels (measured as the
percentage of vessels containing histologically observed
PRBC) and the expression of any of the angiogenic pro-
teins in either vessels, astroglial cells or neurones.CSF levels of circulating Ang-1, Ang-2 and Tie-2 are much
lower than those in plasma
Sixty-two plasma samples of malaria patients were included.
Only a limited number of CSF samples were availableFigure 5 Malaria hemorrhages. Photomicrographs to demonstrate the h
classical ring haemorrhage (B) in the brain tissues of a case of cerebral mal
containing sequestered parasitized erythrocytes and an area of leakage of
contrast the ring haemorrhage shows a central vessel (V), surrounded by a
erythrocytes and leukocytes which have been extravasated from the ruptu
the vascular lumen (Haematoxylin and Eosin staining x400).from cases where IHC had been performed on the corre-
sponding case (n = 12). Although this did not provide
enough power to determine the association of the CSF
levels of the angiogenic markers with the clinical groups
or parameters, the CSF levels of Ang-1, Ang-2 and Tie-2
had not been previously examined in malaria patients.
Median and inter-quartile range of CSF and plasma levels
of Ang-1, Ang-2 and Tie-2 are shown in Table 1. There
were no correlations between baseline plasma concentra-
tions of Ang-1, Ang-2 and Tie-2. The CSF concentrations
of all three markers were significantly lower than the
plasma concentration of themselves in the same cases
(ranging from three to 800 times) (P = 0.0005, Wilcoxon
matched-paired signed-ranks test). However this group
was too small to determine any association between CSF
levels and either plasma levels of the same marker, or clin-
ical outcome.
Plasma levels of Ang-2 and Ang-2/Ang-1 ratio are
significant predictors of fatal outcome
The level of Ang-2 and the ratio of Ang-2/Ang-1
(plasma samples collected at time of admission) were
significantly higher in patients with fatal outcome than
survivors (P = 0.002 and P = 0.029, respectively). Ang-1
and Tie-2 concentrations were not associated with fatal
outcome (Table 1).
In order to assess the prognostic value of Ang-2 and
Ang-2/Ang-1 ratio in assessing a fatal outcome in severe
malaria patients, receiver operating characteristic (ROC)
curves were plotted, and the areas under the ROC
(AUROC) were compared. ROC curves of other laboratory
measures previously shown to be important prognostic
markers of death in severe malaria were also plotted and
compared with those of Ang-2 and Ang-2/Ang-1 ratio.
These included plasma creatinine, lactate and TNF. Ang-2istological characteristics of simple petechial haemorrhage (A) and a
aria. The simple petechial haemorrhage shows a feeding vessel
infected and uninfected erythrocytes into the brain parenchyma. In
zone of clearing and astroglial response, with an outer zone of
red vessel. Such haemorrhages may contain fibrin platelet thrombi in
Table 1 Correlation of circulating Ang-Tie-2 concentrations and clinical complications in malaria patients
Ang-1 (pg/ml) Ang-2 (pg/ml) Tie-2 (pg/ml) Ang-2/Ang1 Ratio
CSF (n=12) 10.27 (8.1-11.1) 609 (388–1059) 247.6 (119–343) -
Plasma (n=62) 543.15 (401–837) 21126 (11590–33595) 28232 (22425–33418) 39.25 (23.14-62.56)
Fatal outcome No (n=30) 591.36 (377.8-862.7) 14883 (9369–24849) 28232 (17288–33106) 30.55 (18.00-48.28)
Yes (n=32) 495.33 (401.0-825.2) 28215 (17040–42921) 28213 (22684–34395) 42.54 (30.57-70.07)
P-Value* 0.95 0.002 0.68 0.029
Hyper-parasitaemia No (n=41) 688.94 (412–976) 18706 (11590–33565) 26013 (22684–34277) 31.26 (18.39-53.22)
Yes (n=21) 495.33 (377–615) 23863 (16110–34426) 28709 (22425–32990) 55.63 (41.60-69.26)
P-Value* 0.08 0.36 0.88 0.01
Jaundice No (n=19) 459.77 (263–787) 9692 (7064–12949) 22907 (15334–29245) 21.94 (8.18-60.95)
Yes (n=43) 591.36 (401–963) 25041 (18288–41865) 28824 (22981–37659) 41.60 (30.17-63.16)
P-Value* 0.13 <0.0001 0.016 0.031
Anaemia No (n=23) 495.33 (401–787) 12848 (9369–24519) 29245 (24960–33418) 28.10 (18.00-44.05)
Yes (n=39) 555.18 (377–988) 26565 (13657–41865) 23800 (19090–35373) 41.70 (30.55-71.30)
P-Value* 0.92 0.004 0.19 0.009
Acute renal failure No (n=23) 495.33 (377–713) 11615 (8376–18706) 27908 (22684–32990) 30.10 (18.00-43.75)
Yes (n=39) 664.38 (401–988) 26788 (18288–43978) 28709 (21318–37659) 41.60 (30.17-69.26)
P-Value* 0.06 <0.0001 0.58 0.06
Hypoglycaemia No (n=44) 567.21 (401–812) 18497 (9829–26217) 28805 (22907–34825) 31.60 (18.78-48.28)
Yes (n=18) 519.24 (377–963) 32948 (13657–45867) 23241 (19853–32679) 57.99 (37.34-85.16)
P-Value* 0.98 0.007 0.29 0.019
Shocked No (n=38) 173.50 (401–988) 19932 (11590–31282) 28767 (22684–37659) 33.94 (18.78-56-24)
Yes (n=24) 459.77 (389–591) 24191 (11841–34918) 27699 (21817–31751) 43.62 (29.77-76.06)
P-Value* 0.053 0.36 0.48 0.13
Hyperlactataemia No (n=39) 688.94 (401–988) 18706 (10415–33565) 27718 (21171–37659) 32.66 (22.77-59.84)
Yes (n=23) 495.33 (377–713) 24601 (12444–35352) 28786 (23501–32990) 43.48 (23.14-70.88)
P-Value* 0.14 0.36 0.69 0.2
Cerebral malaria No (n=29) 495.33 (308–812) 21540 (13657–31021) 24960 (19090–37818) 41.60 (29.66-62.56)
Yes (n=33) 579.28 (436–850) 18706 (9692–34426) 28709 (22918–32990) 37.55 (20.65-63.61)
P-Value* 0.41 0.75 0.49 0.59
Pure cerebral malaria No (n=54) 519.24 (377–837) 24191 (12848–34485) 28633 (22425–35373) 41.35 (29.66-66.28)
Yes (n=8) 713.50 (471–862) 7237 (5178–11321) 25407 (19415–29744) 8.18 (5.65-20.55)
P-Value 0.31 <0.0001 0.27 0.002
Values are presented as median (IQR), *Mann–Whitney U test.
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http://www.malariajournal.com/content/12/1/50has an area under curve (AUROC) of 0.727 (95%CI = 0.6-
0.85), and Ang-2/Ang-1 ratio has an AUROC of 0.662
(0.522-0.802). The prognostic values of Ang-2 and Ang-2/
Ang-1 ratio were not significantly different from each other
or those of plasma creatinine, lactate and TNF (Table 2).
These results confirm the utility of Ang-2 and Ang-2/Ang-
1 ratio as predictive markers of fatal outcome in severe
malaria as shown in previous studies [24,39].
A multivariable logistic regression model was constructed
to assess whether these angiogenic proteins were independ-
ently associated with death, using fatal outcome as the
dependent variable and the angiogenic proteins as well ascreatinine, lactate and TNF as the independent variables. In
this model, none of the markers were independently signifi-
cantly associated with death. Then backward stepwise ap-
proach was used and showed that Ang-2 (OR = 1.000036
per pg/ml, 95%CI = 1.000004–1.000068) and lactate (OR =
1.21 per mmol/L, 95%CI = 1.032–1.435) were independ-
ently associated with fatal outcome. Ang-2 and lactate re-
main significant prognostic markers after adding into the
model other clinical and biochemical parameters, including
age, sex, presence of shock, presence of hypoglycaemia, ad-
mission Glasgow coma score (GCS), admission haematocrit
and parasite count.
Table 2 Comparison of prognostic value of plasma marker concentrations for fatal outcome
Marker AUC (95%CI) Compared to Ang-2 Compared to Ang-2/Ang-1 Ratio
Ang2 0.727 (0.600-0.854)
Ang2/Ang1 Ratio 0.662 (0.522-0.802) 0.82, 0.36
Creatinine 0.708 (0.575-0.840) 0.09, 0.77 0.22, 0.64
Lactate 0.666 (0.528-0.804) 0.4, 0.52 0.01, 0.93
TNF (n=32) 0.696 (0.528-0.863) 0, 1 0.57, 0.75
AUC = area under ROC curve, Data are x2, P-value unless otherwise indicated. All X2 and P-value are calculated from pairwise nonparametric comparison of areas
under ROC curve.
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associated with multiple clinical complications of severe
malaria
High plasma levels of Ang-2 were significantly associated
with the presences of several complications of severe mal-
aria including fatal outcome, jaundice, anaemia, acute
renal failure and hypoglycaemia (Table 1). High Ang-2/
Ang-1 ratios were also associated with the same clinical
complications as Ang-2, but with slightly lower magni-
tude. Hyperparasitaemia was associated with high Ang-2/
Ang-1 ratio and low Ang-1 but not independently asso-
ciated with raised Ang-2. High plasma levels of Tie-2 were
associated with the presence of jaundice but not the other
complications.Plasma levels of Ang-2 is not a biomarker for CM but a
prognostic marker for progressive multi-organ
dysfunction in severe malaria
The presence of cerebral malaria was not related to the
plasma concentrations of Ang-1, Ang-2 and Tie-2; how-
ever, patients with “pure” cerebral malaria (cerebral mal-
aria patients without the other complications of severe
malaria according to WHO 2000 criteria) had significantly
lower Ang-2 concentration and Ang-2/Ang-1 ratio than
the other patients (Table 1).
Plasma Ang-2 concentrations were significantly asso-
ciated with the number of severe complications of severe
malaria occurring in a patient (P <0.0001, Kruskal-Wallis)
(Table 3). This indicated that Ang-2 could be a prognostic
marker of progressive multiple organ dysfunction in severe
malaria. Conversely, there were no correlations between
Ang-1 or Tie-2 concentrations and the number of severity
criteria.Correlation of clinical and laboratory parameters with
plasma levels of Ang-1, Ang-2 and Tie-2 proteins
Spearman’s rank correlations were calculated between
plasma concentrations of Ang-1, Ang-2 or Tie-2 and a
number of clinical and biochemical markers in malaria
patients at admission, including GCS, respiratory rate,
haematocrit, white blood cell count, platelets, parasite
count, liver function tests, creatinine, glucose, electrolytes,
lactate, TNF, and arterial blood gas measures. The summaryof correlations of some important markers of malaria sever-
ity was presented in Table 4.
Plasma Ang-1 concentration was positively correlated
with the admission levels of platelets. This finding may re-
flect platelet production and release of circulating Ang-1
[40]. However Ang-2 and Ang-2/Ang-1 ratio were nega-
tively correlated with platelet counts. There were positive
correlations between body temperature and concentra-
tions of Ang-1 and Tie-2, raising the possibility that these
proteins might play a role in body temperature regulation
in response to the disease. Plasma Ang-2 was correlated
with several indicators of disease activity/severity, includ-
ing increased white cell count, increased liver enzymes
(SGOT and SGPT), decreased renal function (elevated
BUN, creatinine and potassium) and metabolic acidosis
(low pH, high pCO2). Moreover, plasma Ang-2 concentra-
tion was strongly positively correlated with CSF concen-
trations of quinolinic acid and picolinic acid, which have
been previously shown to be strongly associated with acute
renal failure in this group [38]. There were no correlations
between admission parasite count and the plasma levels of
Ang-1 Ang-2 or Tie-2, but admission parasite count was
significantly correlated with the ratio of Ang-2/Ang-1.
Interestingly lactate and pyruvate levels, that could
also contribute to metabolic acidosis, were not corre-
lated with Ang-1, Ang-2 and Tie-2 levels. This finding
suggested that Ang-2 was correlated with metabolic
acidosis in a manner independent of lactate levels
(Spearman’s rho = 0.09, P = 0.47).Plasma levels of Ang-2 and lactate were independently
associated with metabolic acidosis
As described above, plasma Ang-2 levels were closely
correlated with several established prognostic indices of
malaria disease severity and several factors indicating
disease activity. As the various clinical manifestations
and laboratory parameters of severe malaria are inter-
linked, a backward stepwise multivariable linear regres-
sion model was constructed to determine the factors
contributing to plasma Ang-2 level, with plasma level of
Ang-2 as the dependent variable and haematocrit, para-
site count, platelets, white cell counts, creatinine, SGOT,
and lactate as possible explanatory factors. All of these
Table 3 Baseline Ang-2 plasma concentration stratified
by the number of WHO 2000 clinical criteria for severe
malaria
No. of severe
criteria
N Ang-2 (pg/ml) Ang-2/Ang1
1 16 (25.8%) 9730 (7237–15240) 20.55 (8.18-55.63)
2 28 (45.2%) 22616 (14883–34889) 38.53 (28.74-61.15)
3 8 (12.9%) 23532 (15977–28215) 51.66 (17.19-67.77)
4 9 (14.5%) 34485 (31282–43978) 41.60 (37.34-70.88)
5 1 (1.6%) 58192 94
Kruskal-Wallis P <0.0001 P = 0.10
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with the level of Ang-2 in this model and together they
are accounted for 67% (R2 = 0.677) of the variance in
Ang-2 (Model A, Table 5).
There was no correlation between lactate and Ang-2
in the univariate analysis, and that the multivariable lo-
gistic regression model predicting death as an outcome
showed that Ang-2 and lactate were independent factors
contributing to death; however, in this linear regression
model (Model A, Table 5), lactate was a significant inde-
pendent contributing factor to Ang-2. This suggested
that there were other confounding factors related to the
levels of Ang-2 and lactate. This could be metabolic acid-
osis, which is closely related as a complication of severe
malaria to renal failure and hyperlactatemia, as reported
elsewhere [38]. Admission arterial blood pH, representing
one measure of metabolic acidosis, was added into the
model. Adding pH removed the independent significance
of lactate, creatinine, and platelets, so these were removed
from the model; only haematocrit, parasite count, white
cell count and SGOT remained significant factors asso-
ciated with levels of Ang-2 (Model B, Table 5). This sup-
ported the hypothesis that Ang-2 was not directly
correlated with lactate but both of them (together with
renal dysfunction) were correlated with one common
manifestation of severe disease - metabolic acidosis.Conclusions
Plasma concentrations of Ang-2 and the Ang-2/Ang-1
ratio were confirmed as independent predictors of death
in Vietnamese adults with severe falciparum malaria, as
seen in all other adequately powered severe malaria series
studied to date. These include series of adult severe mal-
aria from Indonesia [24], adult CM from India [25], and
paediatric CM series from Uganda [26,27] and Malawi
[28,29]. Patterns of immunostaining of Ang-1, Ang-2 and
Tie-2 in malaria cases were altered in fatal severe malaria
compared to fatal non-malaria cases, especially in neurons
and astroglial cells. However, there were no specific pat-
terns of Ang-1, Ang-2 and Tie-2 expression, either of
neuronal, astroglial or vascular, that differentiated CMfrom non-cerebral severe malaria deaths. Activation of the
Ang-Tie-2 pathway in severe malaria was related to acid-
osis, the number of severity criteria and outcome, but was
not a specific event in the brain during CM.
Previous pathological studies of CM have demonstrated
the presence of EC activation in the cerebral microvascu-
lature [9], which occurs as part of a wider systemic endo-
thelial activation in severe malaria, and which is not
specific to cases that develop coma [10]. The pathophysi-
ology of endothelial activation in CM has been hypothe-
sized to occur in response to both systemic factors (such
as the release of cytokines or a soluble malaria toxin) and
local vasoactive substances such as VEGF or WPB pro-
ducts such as Ang-2. The expression of mediators, which
could influence endothelial reactivity in the brain in CM
has been previously examined, including inducible nitric
oxide synthase [41], the hypoxic inducible protein HIF-1a
and activation of the VEGF signalling pathway [42]. There-
fore this methodology was extended to examine the ex-
pression of the angiopoietins and their receptor Tie-2 in
the brain in CM and NCM cases, to determine the extent
to which they were specific to CM and whether this path-
way showed a direct link to the clinical features of coma
before death.
The lack of significant differences in the patterns or
extent of staining of any of these constituents between
CM and NCM cases is consistent with recent data using
systemic measures of activation of the Ang-2-Tie2 path-
way, where elevated plasma levels of Ang-2 were no
higher in CM than in NCM [24]. Taken together, these
results do not support elevated Ang-2 as a predictive
biomarker for cerebral malaria, as previously proposed
[25,26]. Indeed in the current study, circulating Ang-2
was elevated less in those with CM as the only manifest-
ation than in those with other severe malaria criteria.
The low levels of Ang-2 expression in brain ECs in fatal
CM and NCM, despite elevated plasma concentrations of
Ang-2, was unexpected. It is possible that exocytosis of
cerebral endothelial WPBs at the time of death decreased
immunoreactivity, due to prolonged EC activation, as
stored Ang-2 is rapidly released from WPBs on activation
[18]. Alternatively, raised Ang-2 levels in serum may re-
flect release from the extra-cerebral systemic circulation
in both CM and NCM.
As well as its independent association with fatal out-
come, Ang-2 was associated with number of organ compli-
cations, metabolic acidosis, and acute renal failure, as
previously shown [24]. In contrast, the other major WPB
product increased in severe malaria, vWF, is not associated
with either lactate/metabolic acidosis or fatal outcome in
severe malaria [39,43]. Taken together, these findings do
still suggest a specific pathogenic role for Ang-2 in the
pathways leading to death in severe malaria. Ang-2 com-
petitively binds to Tie-2 receptors blocking the homeostatic
Table 4 Summary of correlations between plasma angiogenic markers and laboratory parameters
Ang-1 Ang-2 Tie-2 Ang-2/Ang1 Ratio
Body temperature rho, P-value* 0.2788, 0.029 ns 0.441, <0.0001
n 61 62
Haematocrit rho, P-value* ns −0.368, 0.003 ns ns
n 62
Parasite count rho, P-value* ns ns ns 0.3, 0.018
n 61
Platelets rho, P-value* 0.305, 0.018 −0.294, 0.022 ns −0.442, <0.0001
n 60 59
White blood cells rho, P-value* ns 0.471, <0.0001 ns ns
n 59
BUN rho, P-value* ns 0.733, <0.0001 ns 0.554, 0.002
n 27 27
Creatinine rho, P-value* ns 0.619, <0.0001 ns 0.293, 0.02
n 62 61
Potassium (K) rho, P-value* ns 0.311, 0.027 ns ns
n 50
SGOT rho, P-value* 0.317, 0.014 0.415, 0.001 ns ns
n 59 60
SGPT rho, P-value* ns 0.283, 0.028 ns ns
n 50
TNF rho, P-value* 0.416, 0.017 ns ns ns
n 32
Lactate rho, P-value* ns ns ns ns
n
Pyruvate rho, P-value* ns ns ns ns
n
PH rho, P-value* ns −0.42, 0.004 ns ns
n 44
pCO2 rho, P-value* ns −0.4832, <0.0001 ns −0.438, 0.003
n 44 43
CSF Kynurenine rho, P-value* ns ns ns ns
n
CSF Quinolinic Acid rho, P-value* ns 0.711, <0.0001 ns 0.625, <0.0001
n 31 30
CSF Picolinic Acid rho, P-value* ns 0.753, <0.0001 ns 0.708, <0.0001
n 31
*Spearman's rank correlation. No adjustments for multiple comparison have been made. All parameters were measured from plasma samples (except indicated as CSF)
at time of admission. ns = not significant.
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sitising ECs to further activation and injury [19]. Ang-2
related amplification of endothelial activation, injury and
microvascular sequestration may thus play a key role in im-
pairment of microvascular perfusion in severe malaria.
Potential limitations to interpretation of immunohisto-
chemical staining patterns include post mortem artefact,which may alter staining due to diffusion or degradation
of proteins, and necessitated the use of control cases. Each
death in an autopsy series gives a ‘snapshot’ effect of path-
ology in an individual case with varying treatment, time to
death and clinical complications of disease, which differ
between cases. Inferring a single unifying pattern of path-
ology with temporal sequence from a group of such cases
Table 5 Summary of multivariate regression models
Model Dependent variable Regression type Independent variables Coefficients (95%CI) Standardized Coefficients P
A Plasma Ang-2 Linear regression Haematocrit −506.65 (−933 to −80) −0.2294042 0.021
Parasite count 0.0116 (0.004 to 0.019) 0.2893166 0.003
R2=0.677 Platelet −0.200 (0.333 to −0.067) −0.27261 0.004
White cell 1.260 (0.746 to 1.774) 0.4790173 <0.0001
Creatinine 1965 (20.2 to 3911) 0.2087163 0.048
SGOT 44.60 (19.61-69.58) 0.3070279 0.001
Lactate −1539 (−2416 to −661.7) −0.3230233 0.001
Constant 23369 (3808 to 42930) - 0.02
B Plasma Ang-2 Linear regression Haematocrit −591.39 (−1111 to −71) −0.275 0.027
Parasite count 0.0111 (0.002 to 0.020) 0.280 0.017
R2=0.623 White cell 1.44 (0.832 to 2.057) 0.352 <0.0001
SGOT 71.96 (23.07 to 120.85) 0.530 0.005
Constant 9200 (−12672 to 31072) - 0.399
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adults is a multi-organ process with high prevalence of
renal, liver, respiratory and metabolic dysfunction as well
as anaemia and cerebral malaria. Hence several factors
may affect the expression of a particular marker as judged
by immunohistochemistry. Despite this, it was reassuring
that the data on plasma levels of Ang-1, Ang-2 and Tie-2
were in keeping with previously published series on these
mediators in severe and fatal malaria [24-29,39]. This
lends weight to the findings that despite the significant
increases in Ang-2 and Ang2/Ang-1 ratio in severe mal-
aria, there was no evidence that this was a process that
was specifically upregulated in the brain in CM versus
NCM cases.
The analysis of the prognostic value of Ang-2 in severe
malaria confirmed, as found in previous studies, that this
marker is predictive of fatal outcome, at a level superior to
previously studied prognostic biomarkers such as serum
lactate. However most studies use a single (admission)
value of serum Ang-2 and have not studied the kinetics
during severe disease. Lactate levels fall rapidly after treat-
ment but in contrast remain high or rise in patients with
fatal outcome despite treatment [44,45]. Data on the kin-
etic responses of Ang-2 and Ang-2/Ang-1 ratio following
treatment would be valuable in interpreting the specificity
of Ang-2 increases in severe malaria.
The effects of Ang-1, Ang-2 and Tie-2 signalling on neu-
rons and glial cells have not been as well studied as endo-
thelium. It was notable that expression of Ang-1, Ang-2
and Tie-2 differed in neurons and glial cells in fatal malaria
cases compared to controls. Recent studies indicate that
Tie-2 signal transduction might have neuroprotective and
mitogenic effects on neuronal cells. Ang-1-Tie-2 signalling
promotes neural outgrowth from dorsal root ganglion cells
[46], supports neuronal differentiation in neural progenitorcells [47], protects against neuronal apoptosis [48] and the
effects of oxygen and glucose starvation [49], both of which
may occur in the brain during the coma of CM. For these
reasons, the increased neuronal Ang-1 expression in asso-
ciation with microvascular haemorrhages may reflect an
adaptive, neuroprotective response to cerebral disease,
where haemorrhages reflect focal damage to BBB function
which are associated with perivascular edema formation
[50]. In a murine model of angiogenesis during experimen-
tal autoimmune encephalomyelitis, temporal changes in
neuronal and glial expression of Ang-1 and vascular expres-
sion of Tie-2 in the spinal cord was seen in concert with
BBB permeability changes [51]. Ang-1 effects on neurons
are not exclusively limited to Tie-2-receptor dependence,
as Ang-1 can induce neurite outgrowth via the β1-integrin
receptor on neurons [52]. Other studies have also found a
positive effect of Ang-2 on neurogenesis and migration of
neuroblasts [53]. It is therefore possible that increased ex-
pression of both Ang-1 and Ang-2 on neuronal cells are
neuroprotective responses in severe malaria whether or not
this involves coma.
Despite the finding that Ang-2 is associated with poor
outcome, the immunohistochemical staining and ELISA
data provided no evidence for direct involvement of this
pathway in the genesis of coma by increases in CM versus
NCM patients. The strong correlation between plasma
Ang-2 levels and Ang2/Ang1 ratio with metabolic acidosis
and increasing number of clinical severity criteria suggests
an association with widespread endothelial activation in
severe disease, even if this does not have a specific effect
on BBB function in the genesis of coma. However the
Ang-2-Tie-2 pathway could be studied using in vitro mod-
els of BBB function in the presence of sequestered,
malaria-infected erythrocytes to investigate this further.
Given the association of plasma Ang-2 with acute renal
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metabolic acidosis in the multivariate analysis, further
studies should examine the role of the Ang-Tie-2 pathway
in regulating blood flow and microvascular pathology in
the kidney in adult severe malaria patients.
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